Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS)
Clinical trial NCT01893372 · COMPLETED
Trial details
- NCT number
- NCT01893372
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2019-01-06
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.